Federated Hermes’s Crinetics Pharmaceuticals CRNX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | – | Sell |
-15,768
| Closed | -$706K | – | 2078 |
|
|
2024
Q2 | $706K | Buy |
15,768
+12,291
| +353% | +$551K | ﹤0.01% | 1217 |
|
|
2024
Q1 | $163K | Buy |
3,477
+3,459
| +19,217% | +$162K | ﹤0.01% | 1525 |
|
|
2023
Q4 | $640 | Sell |
18
-6
| -25% | -$213 | ﹤0.01% | 2001 |
|
|
2023
Q3 | $714 | Buy |
+24
| New | +$714 | ﹤0.01% | 2024 |
|
|
2022
Q2 | – | Sell |
-25,482
| Closed | -$559K | – | 2172 |
|
|
2022
Q1 | $559K | Buy |
25,482
+646
| +3% | +$14.2K | ﹤0.01% | 1421 |
|
|
2021
Q4 | $706K | Buy |
+24,836
| New | +$706K | ﹤0.01% | 1378 |
|
|
2020
Q3 | – | Sell |
-64
| Closed | -$1K | – | 2260 |
|
|
2020
Q2 | $1K | Sell |
64
-29
| -31% | -$453 | ﹤0.01% | 2132 |
|
|
2020
Q1 | $1K | Buy |
+93
| New | +$1K | ﹤0.01% | 2094 |
|